TickerFacts.

A business in context

ARTV research notebook

Read the disclosures. Follow the relationships. Keep the dates in view.

Research JSON

Filing timeline

Download filings CSV

SEC submissions · retrieved 2026-09-08 · 8005 issuers; up to 32 recent company reports and 8 ownership-change filings per issuer

  1. 4 · Ownership change

    Report date 2026-09-03 · 0001193125-26-383625

  2. 4 · Ownership change

    Report date 2026-09-03 · 0001193125-26-383621

  3. 4 · Ownership change

    Report date 2026-09-03 · 0001193125-26-383619

  4. 4 · Ownership change

    Report date 2026-09-03 · 0001193125-26-383618

  5. 4 · Ownership change

    Report date 2026-08-27 · 0001193125-26-377207

  6. 4 · Ownership change

    Report date 2026-08-18 · 0001193125-26-357383

  7. 10-Q · Quarterly report

    Report date 2026-06-30 · 0001193125-26-338029

  8. 8-K · Current report

    Report date 2026-08-06 · 0001193125-26-337986 · Items 2.02,9.01

  9. DEF 14A · Proxy statement

    Report date 2026-09-08 · 0001193125-26-330563

  10. 4 · Ownership change

    Report date 2026-07-29 · 0001231919-26-000817

  11. 4 · Ownership change

    Report date 2026-07-24 · 0001231919-26-000808

  12. 8-K · Current report

    Report date 2026-07-22 · 0001193125-26-312560 · Items 8.01

  13. 8-K · Current report

    Report date 2026-05-18 · 0001193125-26-229714 · Items 5.02

  14. 8-K · Current report

    Report date 2026-05-08 · 0001193125-26-214711 · Items 8.01,9.01

  15. 10-Q · Quarterly report

    Report date 2026-03-31 · 0001193125-26-213242

  16. 8-K · Current report

    Report date 2026-05-08 · 0001193125-26-213239 · Items 2.02,7.01,8.01,9.01

  17. 10-K/A · Annual report

    Report date 2025-12-31 · 0001193125-26-197115

  18. 10-K · Annual report

    Report date 2025-12-31 · 0001193125-26-100135

  19. 8-K · Current report

    Report date 2026-03-10 · 0001193125-26-100131 · Items 2.02,9.01

  20. 8-K · Current report

    Report date 2026-02-18 · 0001193125-26-067509 · Items 5.02

  21. 8-K · Current report

    Report date 2026-02-18 · 0001193125-26-059716 · Items 5.02

  22. 8-K · Current report

    Report date 2025-12-10 · 0001193125-25-317784 · Items 5.02

  23. 8-K · Current report

    Report date 2025-11-12 · 0001193125-25-275902 · Items 7.01,8.01,9.01

  24. 10-Q · Quarterly report

    Report date 2025-09-30 · 0001193125-25-275872

  25. 8-K · Current report

    Report date 2025-11-12 · 0001193125-25-275867 · Items 2.02,9.01

  26. 10-Q · Quarterly report

    Report date 2025-06-30 · 0000950170-25-104045

  27. 8-K · Current report

    Report date 2025-08-06 · 0000950170-25-104028 · Items 2.02,9.01

  28. 8-K · Current report

    Report date 2025-06-24 · 0000950170-25-089942 · Items 5.02,5.07,9.01

  29. 10-Q · Quarterly report

    Report date 2025-03-31 · 0000950170-25-066421

  30. 8-K · Current report

    Report date 2025-05-08 · 0000950170-25-066416 · Items 2.02,9.01

  31. DEF 14A · Proxy statement

    Report date 2025-06-24 · 0001193125-25-101364

  32. 10-K · Annual report

    Report date 2024-12-31 · 0000950170-25-043837

  33. 8-K · Current report

    Report date 2025-03-24 · 0000950170-25-043828 · Items 2.02,9.01

  34. 8-K · Current report

    Report date 2025-01-28 · 0000950170-25-010481 · Items 5.02,9.01

  35. SC 13G/A · Ownership disclosure

    0000905148-24-003191

  36. 10-Q · Quarterly report

    Report date 2024-09-30 · 0000950170-24-125382

  37. 8-K · Current report

    Report date 2024-11-12 · 0000950170-24-125359 · Items 2.02,9.01

  38. 8-K · Current report

    Report date 2024-10-21 · 0001193125-24-241059 · Items 5.02,9.01

  39. SC 13D/A · Ownership disclosure

    0001104659-24-096378

  40. 10-Q · Quarterly report

    Report date 2024-06-30 · 0001193125-24-209924

Reported insider transactions

Download transactions CSV

SEC insider transactions · retrieved 2026-09-07 · 2026 Q2: filings in this completed quarter; not a live transaction feed

Purchases and sales include open-market or private transactions. Grants, exercises and tax withholding are shown separately. Amendments and joint reports can overlap; rows are not a net-buying score. Prices retain the filing's units; consult its footnotes.

Transaction rows by code · counts, not monetary totals
Purchase: 12 transaction rows12PSale: 5 transaction rows5SGrant / award: 2 transaction rows2AExercise / conversion: 0 transaction rows0MTax / exercise payment: 0 transaction rows0FGift: 0 transaction rows0G
P · PurchaseS · SaleA · Grant / awardM · Exercise / conversionF · Tax / exercise paymentG · Gift

19 matching transaction rows.

Transaction / filedReporting ownerTypeSecuritySharesReported price
2026-06-26
2026-06-29
Kolchinsky Peter; RA CAPITAL MANAGEMENT, L.P.; RA Capital Healthcare Fund LP; RA Capital Nexus Fund III, L.P.; RA Capital Nexus Fund, L.P.; Shah Rajeev M.P · Purchase
Acquired
Common Stock1876.08.98
2026-06-25
2026-06-29
Kolchinsky Peter; RA CAPITAL MANAGEMENT, L.P.; RA Capital Healthcare Fund LP; RA Capital Nexus Fund III, L.P.; RA Capital Nexus Fund, L.P.; Shah Rajeev M.P · Purchase
Acquired
Common Stock31000.08.88
2026-06-16
2026-06-16
Kolchinsky Peter; RA CAPITAL MANAGEMENT, L.P.; RA Capital Healthcare Fund LP; RA Capital Nexus Fund III, L.P.; RA Capital Nexus Fund, L.P.; Shah Rajeev M.P · Purchase
Acquired
Common Stock124893.08.89
2026-06-15
2026-06-16
Kolchinsky Peter; RA CAPITAL MANAGEMENT, L.P.; RA Capital Healthcare Fund LP; RA Capital Nexus Fund III, L.P.; RA Capital Nexus Fund, L.P.; Shah Rajeev M.P · Purchase
Acquired
Common Stock15414.08.99
2026-06-12
2026-06-16
Kolchinsky Peter; RA CAPITAL MANAGEMENT, L.P.; RA Capital Healthcare Fund LP; RA Capital Nexus Fund III, L.P.; RA Capital Nexus Fund, L.P.; Shah Rajeev M.P · Purchase
Acquired
Common Stock391019.08.57
2026-06-11
2026-06-11
Kolchinsky Peter; RA CAPITAL MANAGEMENT, L.P.; RA Capital Healthcare Fund LP; RA Capital Nexus Fund III, L.P.; RA Capital Nexus Fund, L.P.; Shah Rajeev M.P · Purchase
Acquired
Common Stock548580.07.91
2026-06-10
2026-06-11
Kolchinsky Peter; RA CAPITAL MANAGEMENT, L.P.; RA Capital Healthcare Fund LP; RA Capital Nexus Fund III, L.P.; RA Capital Nexus Fund, L.P.; Shah Rajeev M.P · Purchase
Acquired
Common Stock103.07.0
2026-06-09
2026-06-11
Kolchinsky Peter; RA CAPITAL MANAGEMENT, L.P.; RA Capital Healthcare Fund LP; RA Capital Nexus Fund III, L.P.; RA Capital Nexus Fund, L.P.; Shah Rajeev M.P · Purchase
Acquired
Common Stock479039.06.91
2026-05-19
2026-05-19
Raymon HeatherS · Sale
Disposed
Common Stock3095.09.01
2026-05-19
2026-05-19
Horan ChristopherS · Sale
Disposed
Common Stock7002.09.01
2026-05-19
2026-05-19
Bush JenniferS · Sale
Disposed
Common Stock8790.09.01
2026-05-19
2026-05-19
Banerjee SubhashisS · Sale
Disposed
Common Stock7037.09.01
2026-05-19
2026-05-19
Aslan FredS · Sale
Disposed
Common Stock27116.09.01
2026-05-18
2026-05-19
Miralles Gines DiegoA · Grant / award
Acquired
Common Stock77500.00.0
2026-05-18
2026-05-19
Miralles Gines DiegoA · Grant / award
Acquired
Employee Stock Option (Right to Buy)
Derivative security
232500.00.0
2026-05-11
2026-05-28
GC Cell Corp; GC Corp.P · Purchase
Acquired
Common Stock1085069.011.52
2026-05-11
2026-05-28
GC Cell Corp; GC Corp.P · Purchase
Acquired
Common Stock347222.011.52
2026-05-11
2026-05-13
Kolchinsky Peter; RA CAPITAL MANAGEMENT, L.P.; RA Capital Healthcare Fund LP; RA Capital Nexus Fund III, L.P.; RA Capital Nexus Fund, L.P.; Shah Rajeev M.P · Purchase
Acquired
Common Stock6510416.011.52
2026-05-11
2026-05-13
Kolchinsky Peter; RA CAPITAL MANAGEMENT, L.P.; RA Capital Healthcare Fund LP; RA Capital Nexus Fund III, L.P.; RA Capital Nexus Fund, L.P.; Shah Rajeev M.P · Purchase
Acquired
Pre-Funded Warrant (Right to Buy)
Derivative security
2170138.011.52

Identity & relationships

Wikidata structured data · retrieved 2026-09-07 · 1611 unambiguous CIK-linked entities; coverage is incomplete

These are sourced identity and relationship claims, with incomplete coverage. Headquarters locations do not describe sales, assets or operating exposure.

SEC issuer · 0001817241Artiva Biotherapeutics, Inc.

No parent relationship is available in this import; this is not proof of independence.

No verified LEI join available.

GLEIF legal entity reference data · retrieved 2026-09-07 · 1177 checked identities; 0 unavailable records

Search names and former names

    Revenue in constant purchasing power

    USD revenue expressed in 2026-07 consumer-price dollars. Each annual period uses a CPI-U average weighted by the days in its actual reporting interval. This is a purchasing-power comparison, not a company-specific price or volume measure.

    Year endedReported USD revenueCPI-adjusted USD revenue
    2024-12-31$251.0K$267.2K
    2023-12-31$33.49M$36.70M

    Bureau of Labor Statistics · retrieved 2026-09-08 · 9 selected series; gaps remain missing

    Explore the CPI history ↗